Transcription
Safety Data Sheet according to (EC) No 1907/2006 as amendedPage 1 of 20SDS No. : 316211V010.0Revision: 14.10.2020printing date: 23.02.2021Replaces version from: 19.08.2020Loctite 243SECTION 1: Identification of the substance/mixture and of the company/undertaking1.1. Product identifierLoctite 243LoctiteSchrau1.2. Relevant identified uses of the substance or mixture and uses advised againstIntended use:Adhesive1.3. Details of the supplier of the safety data sheetHenkel LtdWood Lane EndHP2 4RQHemel Hempstead243 bensicherung 243Festo SE&Ruiter S Co. KGtrasse 82D-73734Esslingenwww.Festo.com/eGreat BritainPhone:Fax-no.: 44 1442 278000 44 1442 278071ua-productsafety.uk@henkel.com1.4. Emergency telephone number24 Hours Emergency Tel: 44 (0)1442 278497SECTION 2: Hazards identification2.1. Classification of the substance or mixtureClassification (CLP):Skin irritationH315 Causes skin irritation.Serious eye irritationH319 Causes serious eye irritation.Skin sensitizerH317 May cause an allergic skin reaction.Specific target organ toxicity - single exposureH335 May cause respiratory irritation.Target organ: respiratory tract irritationChronic hazards to the aquatic environmentH411 Toxic to aquatic life with long lasting effects.2.2. Label elementsLabel elements (CLP):Category 2Category 2Category 1Category 3Category 2n/msds
SDS No.: 316211 V010.0 Loctite 243Page 2 of 20Hazard pictogram:Tetramethylene dimethacrylateContainsmaleic acidAcetic acid, 2-phenylhydrazideSignal word:WarningHazard statement:H315 Causes skin irritation.H317 May cause an allergic skin reaction.H319 Causes serious eye irritation.H335 May cause respiratory irritation.H411 Toxic to aquatic life with long lasting effects.Precautionary statement:"***" ***For consumer use only: P101 If medical advice is needed, have productcontainer or label at hand. P102 Keep out of reach of children. P501 Dispose ofcontents/container in accordance with national regulation.***Precautionary statement:PreventionP261 Avoid breathing vapors.P273 Avoid release to the environment.P280 Wear protective gloves.Precautionary statement:ResponseP302 P352 IF ON SKIN: Wash with plenty of soap and water.P333 P313 If skin irritation or rash occurs: Get medical advice/attention.P337 P313 If eye irritation persists: Get medical advice/attention.2.3. Other hazardsNone if used properly.Not fulfilling Persistent, Bioaccumulative and Toxic (PBT), very Persistent and very Bioaccumulative (vPvB) criteria.SECTION 3: Composition/information on ingredients3.2. MixturesGeneral chemical description:Anaerobic adhesive
SDS No.: 316211 V010.0 Loctite 243Page 3 of 20Declaration of the ingredients according to CLP (EC) No 1272/2008:Hazardous componentsCAS-No.Tetramethylene dimethacrylate2082-81-7EC NumberREACH-Reg 5- 50 %Skin Sens. 1BH317Skin Irrit. 2H315Eye Irrit. 2H319STOT SE 3H335Acute Tox. 4; OralH302Aquatic Chronic 2H411Eye Irrit. 2H319Aquatic Chronic 2H411Aquatic Acute 1H400Aquatic Chronic 1H410M factor (Acute Aquat Tox): 10 M factor(Chron Aquat Tox): 10Acute Tox. 4; DermalH312STOT RE 2H373Acute Tox. 4; OralH302Org. Perox. EH242Acute Tox. 3; InhalationH331Aquatic Chronic 2H411Skin Corr. 1BH314Acute Tox. 3; OralH301Skin Irrit. 2H315Skin Sens. 1H317Eye Irrit. 2H319STOT SE 3; InhalationH335Carc. 2H351Acute Tox. 4; DermalH312Acute Tox. 4; OralH302Eye Irrit. 2H319STOT SE 3H335Skin Irrit. 2H315Skin Sens. 1H317Acute Tox. 3; OralH301Skin Irrit. 2; DermalH315Skin Sens. 1H317Eye Irrit. 2H319Acute Tox. 1; InhalationH330STOT SE 3; InhalationH335Aquatic Acute 119489756-175- 10 -2ethyl-1,3-propanediyl diacrylate94108-97-1Fatty acid amide126098-16-6302-434-91- 5 %484-050-201-0000020228-740,25- 2,5 %Cumene hydroperoxide80-15-9201-254-701-2119475796-190,1- 1 %Acetic acid, 2-phenylhydrazide114-83-0204-055-30,1- 1 %maleic acid110-16-7203-742-501-2119488705-250,1- 1 %1,4-Naphthalenedione130-15-4204-977-60,01- 0,1 %
SDS No.: 316211 V010.0 Loctite 243Page 4 of 20H400Aquatic Chronic 1H410M factor (Acute Aquat Tox): 10 M factor(Chron Aquat Tox): 10For full text of the H - statements and other abbreviations see section 16 "Other information".Substances without classification may have community workplace exposure limits available.SECTION 4: First aid measures4.1. Description of first aid measuresInhalation:Move to fresh air. If symptoms persist, seek medical advice.Skin contact:Rinse with running water and soap.Obtain medical attention if irritation persists.Eye contact:Rinse immediately with plenty of running water (for 10 minutes), seek medical attention from a specialist.Ingestion:Rinse mouth, drink 1-2 glasses of water, do not induce vomiting, consult a doctor.4.2. Most important symptoms and effects, both acute and delayedSKIN: Rash, Urticaria.EYE: Irritation, conjunctivitis.SKIN: Redness, inflammation.RESPIRATORY: Irritation, coughing, shortness of breath, chest tightness.4.3. Indication of any immediate medical attention and special treatment neededSee section: Description of first aid measuresSECTION 5: Firefighting measures5.1. Extinguishing mediaSuitable extinguishing media:Carbon dioxide, foam, powderFine water sprayExtinguishing media which must not be used for safety reasons:None known5.2. Special hazards arising from the substance or mixtureIn the event of a fire, carbon monoxide (CO), carbon dioxide (CO2) and nitrogen oxides (NOx) can be released.5.3. Advice for firefightersWear self-contained breathing apparatus and full protective clothing, such as turn-out gear.Additional information:In case of fire, keep containers cool with water spray.SECTION 6: Accidental release measures6.1. Personal precautions, protective equipment and emergency proceduresAvoid contact with skin and eyes.Ensure adequate ventilation.Wear protective equipment.
SDS No.: 316211 V010.0 Loctite 2436.2. Environmental precautionsDo not empty into drains / surface water / ground water.6.3. Methods and material for containment and cleaning upFor small spills wipe up with paper towel and place in container for disposal.For large spills absorb onto inert absorbent material and place in sealed container for disposal.Dispose of contaminated material as waste according to Section 13.6.4. Reference to other sectionsSee advice in section 8SECTION 7: Handling and storage7.1. Precautions for safe handlingUse only in well-ventilated areas.Prolonged or repeated skin contact should be avoided to minimise any risk of sensitisation.Avoid skin and eye contact.See advice in section 8Hygiene measures:Good industrial hygiene practices should be observed.Do not eat, drink or smoke while working.Wash hands before work breaks and after finishing work.7.2. Conditions for safe storage, including any incompatibilitiesEnsure good ventilation/extraction.Refer to Technical Data Sheet7.3. Specific end use(s)AdhesivePage 5 of 20
SDS No.: 316211 V010.0 Loctite 243Page 6 of 20SECTION 8: Exposure controls/personal protection8.1. Control parametersOccupational Exposure LimitsValid forGreat BritainIngredient [Regulated substance]ppmSilane, dichlorodimethyl-, reaction productswith silica68611-44-9[SILICA, AMORPHOUS, RESPIRABLEDUST]Silane, dichlorodimethyl-, reaction productswith silica68611-44-9[SILICA, AMORPHOUS, INHALABLEDUST]Ethene, homopolymer9002-88-4[DUST, INHALABLE DUST]Ethene, homopolymer9002-88-4[DUST, RESPIRABLE DUST]Propane-1,2-diol57-55-6[PROPANE-1,2-DIOL, 2-DIOL, TOTAL VAPOURAND PARTICULATES]mg/m3Value type2,4Time Weighted Average(TWA):EH40 WEL6Time Weighted Average(TWA):EH40 WEL10Time Weighted Average(TWA):EH40 WEL4Time Weighted Average(TWA):EH40 WEL10Time Weighted Average(TWA):EH40 WEL474Time Weighted Average(TWA):EH40 WELmg/m3Value type10Time Weighted Average(TWA):IR OEL4Time Weighted Average(TWA):IR OEL10Time Weighted Average(TWA):IR OEL470Time Weighted Average(TWA):IR OELShort term exposure limitcategory / RemarksRegulatory listOccupational Exposure LimitsValid forIrelandIngredient [Regulated substance]Ethene, homopolymer9002-88-4[DUSTS NON-SPECIFIC]Ethene, homopolymer9002-88-4[DUSTS 0Short term exposure limitcategory / RemarksRegulatory list
SDS No.: 316211 V010.0 Loctite 243Page 7 of 20Predicted No-Effect Concentration (PNEC):Name on listEnvironmental ExposureCompartment periodTetramethylene dimethacrylate2082-81-7Tetramethylene dimethacrylate2082-81-7Tetramethylene dimethacrylate2082-81-7aqua(freshwater)aqua ment plant(STP)sediment(freshwater)sediment(marine water)SoilTetramethylene dimethacrylate2082-81-7Tetramethylene dimethacrylate2082-81-7Tetramethylene dimethacrylate2082-81-7Tetramethylene 1,3-propanediyl thyl]butoxy]methyl]-2ethyl-1,3-propanediyl thyl]butoxy]methyl]-2ethyl-1,3-propanediyl thyl]butoxy]methyl]-2ethyl-1,3-propanediyl thyl]butoxy]methyl]-2ethyl-1,3-propanediyl thyl]butoxy]methyl]-2ethyl-1,3-propanediyl thyl]butoxy]methyl]-2ethyl-1,3-propanediyl diacrylate94108-97-1Fatty acid amide126098-16-6Fatty acid amide126098-16-6Fatty acid amide126098-16-6Fatty acid amide126098-16-6Valuemg/lppm0,043 mg/lRemarksmg/kg0,004 mg/l0,098 mg/l2 mg/l3,12 mg/kg0,312mg/kg0,573mg/kgaqua(freshwater)aqua (marinewater)freshwater intermittentsediment(freshwater)sediment(marine water)Soil0,007 mg/lsewagetreatment plant(STP)oral10 mg/laqua(freshwater)0,0012mg/l0,001 mg/l0,07 096mg/kgsediment(marine getreatment plant(STP)100 mg/laqua(intermittentreleases)0,012 mg/laqua (marinewater)0,00012mg/laqua(freshwater)aqua rine water)0,000146mg/l0,0146 g/l0,00025mg/l5,554mg/kgothers
SDS No.: 316211 V010.0 Loctite 243Fatty acid amide126098-16-6Fatty acid amide126098-16-6Fatty acid operoxide80-15-9Maleic acid110-16-7Maleic acid110-16-7Maleic acid110-16-7Maleic acid110-16-7Maleic acid110-16-7Maleic acid110-16-7Maleic acid110-16-7Page 8 of reatment plant(STP)aqua(freshwater)10 mg/laqua Sewagetreatment plant0,031 mg/l0,0031mg/l0,35 mg/lsediment(freshwater)0,023mg/kgsediment(marine treatment plant(STP)aqua (marinewater)sediment(marine water)Soil0,1 mg/l0,4281mg/l0,334mg/kg44,6 mg/l0,01 mg/l0,0334mg/kg0,0415mg/kg
SDS No.: 316211 V010.0 Loctite 243Page 9 of 20Derived No-Effect Level (DNEL):Name on listApplicationAreaWorkersRoute ofExposuredermalTetramethylene lene Tetramethylene amethylene xy]methyl]-2ethyl-1,3-propanediyl thyl]butoxy]methyl]-2ethyl-1,3-propanediyl diacrylate94108-97-1Fatty acid lene dimethacrylate2082-81-7Health EffectExposureTimeValueLong termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effectsAcute/short termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effects4,2 mg/kgdermalLong termexposure systemic effects1,67 mg/kgGeneralpopulationoral8,3 mg/kgFatty acid amide126098-16-6GeneralpopulationdermalFatty acid amide126098-16-6WorkersdermalFatty acid amide126098-16-6GeneralpopulationinhalationFatty acid imethylbenzylhydroperoxide80-15-9Maleic acid110-16-7WorkersinhalationWorkersdermalMaleic acid110-16-7WorkersdermalMaleic acid110-16-7WorkersdermalMaleic acid110-16-7WorkersdermalMaleic acid110-16-7WorkersinhalationMaleic acid110-16-7WorkersinhalationMaleic acid110-16-7WorkersinhalationLong termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effectsLong termexposure systemic effectsAcute/short termexposure - localeffectsLong termexposure - localeffectsAcute/short termexposure systemic effectsLong termexposure systemic effectsAcute/short termexposure - localeffectsLong termexposure systemic effectsLong termexposure - localeffects14,5 mg/m34,3 mg/m32,5 mg/kg2,5 mg/kg134,4 mg/m31,5 mg/kg2,12 mg/m35,88 mg/m
23.02.2021 · Loctite 243 printing date SDS No. : 316211 V010.0 Revision: 14.10.2020: 23.02.2021 Replaces version from: 19.08.2020 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Loctite 243 1.2. Relevant identified uses of the substance or mixture and uses advised against Intended use: Adhesive 1.3. Details of the supplier of the safety
